Cover Image for Commercial Geography: How The Choice of Market Determines Your Capital, Your Partners And Your First Contract
Cover Image for Commercial Geography: How The Choice of Market Determines Your Capital, Your Partners And Your First Contract
Avatar for Sclr labs
Presented by
Sclr labs

Commercial Geography: How The Choice of Market Determines Your Capital, Your Partners And Your First Contract

Register to See Address
London, United Kingdom
Get Tickets
Welcome! Please choose your desired ticket type:
About Event

Most founders choose a market by convenience. Where the science was developed, where the first customer conversation happened, where a competitor went.

In practice the market decision sets everything downstream. Your pricing, the evidence you need, who holds the budget, how long procurement takes, and which investors will fund the plan. It also decides which large organisations are worth approaching and what they need to see before they sign.

This session is designed as a practical founder discussion around how commercial market decisions and capital decisions shape each other in real fundraising and partnering environments.

Flow

We will begin with a short briefing (c.15 mins) followed by a more interactive discussion around:

  • choosing a first commercial market on evidence rather than convenience

  • who holds budget inside a health system, and what moves a procurement decision

  • reaching the real decision maker inside pharma, distributors and institutional funders

  • pricing and reimbursement as part of the deal rather than a later problem

  • which investors, in which regions, fund which commercial strategies

  • common mistakes when approaching large organisations

The room will be kept small (15 to 17 founders) to allow for direct discussion and questions.

Who this is for

Life science founders currently raising or preparing for investor and partner conversations, particularly at Seed to Series A stage. Diagnostics, tools, device and platform companies preparing a first launch.

Expert

Anna M. Detert — Principal at Gloucester Ventures

Anna invests at pre-seed and angel stage in biopharmaceutical tools and diagnostics, and works with founders on investor targeting, market strategy and pitch preparation.

With 25 years across biopharma, diagnostics, venture capital and private equity, including a partnership in KPMG UK's healthcare strategy team and earlier product development work at Bayer Diagnostics, she brings direct experience of how investors and large healthcare organisations assess a company's commercial plan.

A second expert will be announced shortly.

Dress: business casual or business

Photography

By attending, you consent to being photographed and filmed for promotional use. If you would prefer not to have your photos used or details shared, please let us know, and we will respect your preferences.

Location
Please register to see the exact location of this event.
London, United Kingdom
Avatar for Sclr labs
Presented by
Sclr labs